PlainRecalls
LowClass IIITerminated

FDA Devices recall · Reported August 11, 2021

Cardinal Health Beta-Hydroxybutyrate . in vitro diagnostic reagent.

Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.

Recall #
Z-2202-2021
Affected scope
3,940 units
Initiated
July 12, 2021
Compiled from official public sources by the editorial team.
Verify with FDA Devices →
View my saved recalls

Stanbio Laboratory, LP recalled Cardinal Health Beta-Hydroxybutyrate . in vitro diagnostic reagent. - a low-severity action.

Cardinal Health Beta-Hydroxybutyrate . in vitro diagnostic reagent. was recalled by Stanbio Laboratory, LP in August 11, 2021. Reason: Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Qual…. Check the official notice for the remedy. Verify recall #Z-2202-2021 with the FDA Devices before acting.

The recall

Stanbio Laboratory, LP issued this low-severity FDA Devices recall-Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Qual….

Low
severity level
4K units
affected scope
Class III
classification
August 11, 2021
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-2202-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Devices action (record #Z-2202-2021) was formally reported on August 11, 2021, with the manufacturer initiating the action on July 12, 2021. It is classified under Low severity (Class III), with a current status of Terminated. Stanbio Laboratory, LP is listed as the recalling firm, operating out of Boerne, TX. Federal records list the affected scope as 3,940 units.

The documented reason for this recall is: Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values. Distribution data in the federal record shows the product reached: Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MO, NC, NH, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, T…. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 40,409 medical devices recalls on record

-1,00001,0002,0003,0004,0005,000 20052008201120142017202020232026 1,243

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Low

Affected scope

3,940 units

Related Recalls

6

6 from same agency

Product description

Cardinal Health Beta-Hydroxybutyrate . in vitro diagnostic reagent.

Reason for recall

Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Terminated
Recall number Z-2202-2021
Date reported August 11, 2021
Date initiated July 12, 2021
Recalling firm Stanbio Laboratory, LP
Firm location Boerne, TX
Affected scope 3,940 units
Distribution Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MO, NC, NH, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, TN, TX, VA, VT, WA, W…

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

3,940 units units affected - limited or regional distribution scale.

Regional (<10K units) ✓ This recall
Multi-state (10K – 100K units) -
Large-scale (100K – 1M units) -
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-2202-2021) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Cardinal Health Beta-Hydroxybutyrate . in vitro diagnostic reagent.. Recalled by Stanbio Laboratory, LP. Units affected: 3,940 units.
Why was this product recalled?
Deterioration in the stability of the reagents which has resulted in lower than expected or out of range Quality Control values.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 11, 2021. Severity: Low. Recall number: Z-2202-2021.
Where was the recalled product distributed?
Distribution: Worldwide distribution - U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, MI, MO, NC, NH, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, TN, TX, VA, VT, WA, WI, and WV. The countries of Australia, Canada, Chile, Federal Republic of Germany, Hong Kong, Singapore, Taiwan, Thailand, United Kingdom, and Viet Nam..
How do I check if my product is affected by a recall?
Check the product description and recall number (Z-2202-2021) against your product. Visit the official FDA Devices website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with GE HealthCare TRADE IN CARESCAPE TELEMETRY SERVER ARK-2250L… →

Browse all Medical Devices recalls →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Devices, reported August 11, 2021.

  • Source: FDA - Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC - Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA - National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.